Sunshine Biopharma SBFM Stock
Sunshine Biopharma Price Chart
Sunshine Biopharma SBFM Financial and Trading Overview
| Sunshine Biopharma stock price | 2.04 USD |
| Previous Close | 2.13 USD |
| Open | 2.06 USD |
| Bid | 1.53 USD x 200 |
| Ask | 2.62 USD x 200 |
| Day's Range | 2.03 - 2.13 USD |
| 52 Week Range | 2.01 - 24.3 USD |
| Volume | 68.32K USD |
| Avg. Volume | 1.61M USD |
| Market Cap | 4.35M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 56 USD |
SBFM Valuation Measures
| Enterprise Value | -5128953 USD |
| Trailing P/E | N/A |
| Forward P/E | 0.01026026 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.12265552 |
| Price/Book (mrq) | 0.04676948 |
| Enterprise Value/Revenue | -0.145 |
| Enterprise Value/EBITDA | 1.211 |
Trading Information
Sunshine Biopharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -86.24% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 24.3 USD |
| 52 Week Low | 2.01 USD |
| 50-Day Moving Average | 6.4 USD |
| 200-Day Moving Average | 11.97 USD |
SBFM Share Statistics
| Avg. Volume (3 month) | 1.61M USD |
| Avg. Daily Volume (10-Days) | 157.19K USD |
| Shares Outstanding | 2.12M |
| Float | 497.44K |
| Short Ratio | 0.04 |
| % Held by Insiders | 0.48% |
| % Held by Institutions | 12.86% |
| Shares Short | 144.3K |
| Short % of Float | 6.83% |
| Short % of Shares Outstanding | 6.80% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -17.016% |
| Operating Margin (ttm) | -17.25% |
| Gross Margin | 32.98% |
| EBITDA Margin | -11.92% |
Management Effectiveness
| Return on Assets (ttm) | -10.020% |
| Return on Equity (ttm) | -27.31% |
Income Statement
| Revenue (ttm) | 35.49M USD |
| Revenue Per Share (ttm) | 75.39 USD |
| Quarterly Revenue Growth (yoy) | -9.099% |
| Gross Profit (ttm) | 11.71M USD |
| EBITDA | -4234493 USD |
| Net Income Avi to Common (ttm) | -6039450 USD |
| Diluted EPS (ttm) | -12.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.91M USD |
| Total Cash Per Share (mrq) | 13.81 USD |
| Total Debt (mrq) | 744.84K USD |
| Total Debt/Equity (mrq) | 3.46 USD |
| Current Ratio (mrq) | 4.216 |
| Book Value Per Share (mrq) | 43.832 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5708171 USD |
| Levered Free Cash Flow (ttm) | -4710076 USD |
Profile of Sunshine Biopharma
| Country | United States |
| State | FL |
| City | Fort Lauderdale |
| Address | 333 Las Olas Way |
| ZIP | 33301 |
| Phone | 954 330 0684 |
| Website | https://sunshinebiopharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 50 |
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Q&A For Sunshine Biopharma Stock
What is a current SBFM stock price?
Sunshine Biopharma SBFM stock price today per share is 2.04 USD.
How to purchase Sunshine Biopharma stock?
You can buy SBFM shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sunshine Biopharma?
The stock symbol or ticker of Sunshine Biopharma is SBFM.
Which industry does the Sunshine Biopharma company belong to?
The Sunshine Biopharma industry is Drug Manufacturers - Specialty & Generic.
How many shares does Sunshine Biopharma have in circulation?
The max supply of Sunshine Biopharma shares is 1.62M.
What is Sunshine Biopharma Price to Earnings Ratio (PE Ratio)?
Sunshine Biopharma PE Ratio is now.
What was Sunshine Biopharma earnings per share over the trailing 12 months (TTM)?
Sunshine Biopharma EPS is -12.5 USD over the trailing 12 months.
Which sector does the Sunshine Biopharma company belong to?
The Sunshine Biopharma sector is Healthcare.
Sunshine Biopharma SBFM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}